Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 15 studies | 37% ± 17% | |
lung | 14 studies | 28% ± 8% | |
peripheral blood | 14 studies | 32% ± 10% | |
eye | 9 studies | 48% ± 17% | |
kidney | 8 studies | 24% ± 9% | |
intestine | 8 studies | 25% ± 10% | |
lymph node | 5 studies | 31% ± 6% | |
pancreas | 4 studies | 55% ± 24% | |
bone marrow | 4 studies | 28% ± 10% | |
uterus | 4 studies | 32% ± 8% | |
breast | 4 studies | 23% ± 3% | |
liver | 4 studies | 44% ± 18% | |
heart | 3 studies | 18% ± 2% | |
adipose | 3 studies | 23% ± 7% | |
skin | 3 studies | 20% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 7098.83 | 258 / 258 | 100% | 201.55 | 230 / 230 |
brain | 100% | 15123.02 | 2642 / 2642 | 100% | 137.27 | 705 / 705 |
thymus | 100% | 5801.25 | 653 / 653 | 100% | 84.64 | 605 / 605 |
esophagus | 100% | 4004.57 | 1444 / 1445 | 100% | 35.56 | 183 / 183 |
kidney | 100% | 3912.91 | 89 / 89 | 100% | 48.84 | 900 / 901 |
prostate | 100% | 4970.77 | 244 / 245 | 100% | 63.20 | 502 / 502 |
breast | 100% | 5319.64 | 459 / 459 | 100% | 51.40 | 1113 / 1118 |
lung | 100% | 5157.22 | 576 / 578 | 100% | 40.48 | 1152 / 1155 |
skin | 100% | 4182.63 | 1806 / 1809 | 99% | 64.33 | 469 / 472 |
bladder | 100% | 4409.10 | 21 / 21 | 99% | 39.48 | 499 / 504 |
uterus | 100% | 5364.11 | 170 / 170 | 99% | 44.16 | 454 / 459 |
ovary | 100% | 6844.56 | 180 / 180 | 99% | 30.64 | 425 / 430 |
intestine | 100% | 4262.67 | 966 / 966 | 98% | 32.59 | 519 / 527 |
stomach | 97% | 2964.17 | 348 / 359 | 99% | 31.28 | 284 / 286 |
pancreas | 89% | 1980.65 | 293 / 328 | 100% | 55.57 | 178 / 178 |
liver | 92% | 2034.04 | 209 / 226 | 97% | 25.46 | 392 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 80.41 | 29 / 29 |
spleen | 100% | 5657.38 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 34.12 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 29.40 | 1 / 1 |
blood vessel | 100% | 6254.66 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 5454.88 | 1202 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 46.25 | 79 / 80 |
muscle | 99% | 3256.74 | 792 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 4164.43 | 890 / 929 | 0% | 0 | 0 / 0 |
heart | 95% | 4001.93 | 816 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010569 | Biological process | regulation of double-strand break repair via homologous recombination |
GO_1901224 | Biological process | positive regulation of non-canonical NF-kappaB signal transduction |
GO_0031848 | Biological process | protection from non-homologous end joining at telomere |
GO_0032204 | Biological process | regulation of telomere maintenance |
GO_0010833 | Biological process | telomere maintenance via telomere lengthening |
GO_0032205 | Biological process | negative regulation of telomere maintenance |
GO_0048239 | Biological process | negative regulation of DNA recombination at telomere |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0001933 | Biological process | negative regulation of protein phosphorylation |
GO_0016233 | Biological process | telomere capping |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0070198 | Biological process | protein localization to chromosome, telomeric region |
GO_0032206 | Biological process | positive regulation of telomere maintenance |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0000723 | Biological process | telomere maintenance |
GO_0007004 | Biological process | telomere maintenance via telomerase |
GO_0000228 | Cellular component | nuclear chromosome |
GO_0000783 | Cellular component | nuclear telomere cap complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016604 | Cellular component | nuclear body |
GO_0005737 | Cellular component | cytoplasm |
GO_0000781 | Cellular component | chromosome, telomeric region |
GO_0070187 | Cellular component | shelterin complex |
GO_0001673 | Cellular component | male germ cell nucleus |
GO_0005634 | Cellular component | nucleus |
GO_0042162 | Molecular function | telomeric DNA binding |
GO_0019902 | Molecular function | phosphatase binding |
GO_0098505 | Molecular function | G-rich strand telomeric DNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | TERF2IP |
Protein name | Telomeric repeat-binding factor 2-interacting protein 1 (TERF2-interacting telomeric protein 1) (TRF2-interacting telomeric protein 1) (Dopamine receptor-interacting protein 5) (Repressor/activator protein 1 homolog) (RAP1 homolog) (hRap1) Telomeric repeat-binding factor 2-interacting protein 1 (TERF2-interacting telomeric protein 1) (Repressor/activator protein 1 homolog) TERF2 interacting protein |
Synonyms | DRIP5 RAP1 PP8000 |
Description | FUNCTION: Acts both as a regulator of telomere function and as a transcription regulator. Involved in the regulation of telomere length and protection as a component of the shelterin complex (telosome). In contrast to other components of the shelterin complex, it is dispensible for telomere capping and does not participate in the protection of telomeres against non-homologous end-joining (NHEJ)-mediated repair. Instead, it is required to negatively regulate telomere recombination and is essential for repressing homology-directed repair (HDR), which can affect telomere length. Does not bind DNA directly: recruited to telomeric double-stranded 5'-TTAGGG-3' repeats via its interaction with TERF2. Independently of its function in telomeres, also acts as a transcription regulator: recruited to extratelomeric 5'-TTAGGG-3' sites via its association with TERF2 or other factors, and regulates gene expression. When cytoplasmic, associates with the I-kappa-B-kinase (IKK) complex and acts as a regulator of the NF-kappa-B signaling by promoting IKK-mediated phosphorylation of RELA/p65, leading to activate expression of NF-kappa-B target genes. . FUNCTION: Acts both as a regulator of telomere function and as a transcription regulator. Involved in the regulation of telomere length and protection as a component of the shelterin complex (telosome). Does not bind DNA directly: recruited to telomeric double-stranded 5'-TTAGGG-3' repeats via its interaction with terf2. Independently of its function in telomeres, also acts as a transcription regulator: recruited to extratelomeric 5'-TTAGGG-3' sites via its association with terf2 or other factors, and regulates gene expression. . |
Accessions | H3BMI8 ENST00000300086.5 ENST00000653858.1 Q9NYB0 ENST00000569234.1 ENST00000564671.2 H3BR63 A0A590UJT3 |